[ad_1] Take-Two Interactive Software, Inc. (NASDAQ: TTWO) reported a wider net loss, on a reported basis, for the first quarter of 2025, despite the gaming giant’s revenues increasing year-over-year. The top line also beat estimates. June quarter revenues increased to…
[ad_1] Image source: Getty Images The BAE Systems (LSE:BA) share price has had a great run in the last year, climbing by almost 25%. However, there are threats to the FTSE 100 company’s gains as there is some worry about…
[ad_1] Shares of Beyond Meat, Inc. (NASDAQ: BYND) soared over 20% on Thursday, after the company delivered better-than-expected sales results for the second quarter of 2024 a day ago. Earnings, however, fell short of estimates. The stock has dropped 10%…
[ad_1] Image source: Getty Images I do believe that Lloyds (LSE: LLOY) shares offer the opportunity to build wealth through dividends and future growth. However, there are several challenges the firm faces that could hurt earnings and returns. For that…
[ad_1] Gaming company Take-Two Interactive Software, Inc. (NASDAQ: TTWO) will be reporting earnings for the first quarter of 2025 today after markets close. Listen to Take-Two’s earnings call live and check the real-time transcript Take-Two has guided for total revenue of…
[ad_1] Image source: Getty Images Periods of high volatility in the stock market can make for some stressful days as an investor. This is particularly true if I hold high-growth stocks or penny shares. Both are known to have sharp…
[ad_1] Packaging solutions provider Sealed Air Corp. (NYSE: SEE) on Thursday announced results for the second quarter of 2024, reporting an increase in adjusted earnings despite lower net sales. Net sales decreased 2.6% annually to $1.35 billion in the second…
[ad_1] Image source: Getty Images There are few better signs than seeing your stock picks surge after reporting earnings, and that’s what’s happening to the Beazley (LSE:BEZ) share price on Thursday (8 August). The company’s earnings for the first half…
[ad_1] Eli Lilly and Company (NYSE: LLY) on Thursday reported a double-digit increase in revenues and profit for the second quarter of 2024. The pharma giant also raised its full-year guidance. Worldwide revenue increased 36% annually to $11.3 billion in…
[ad_1] Image source: Getty Images Hikma Pharmaceuticals (LSE: HIK), the London-listed generic drug maker, has reported its half-year results for 2024, painting a somewhat mixed picture for the company. While group revenue grew a solid 10%, core operating profit was…